查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1544015

全球轉染試劑與設備市場

Transfection Reagents and Equipment
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2030年全球轉染試劑和設備市場將達18億美元

2023年全球轉染試劑和設備市場估計為12億美元，預計到2030年將達到18億美元，2023-2030年分析期間複合年成長率為6.1%。轉染試劑是本報告分析的細分市場之一，預計複合年成長率為 6.6%，到分析期結束時將達到 12 億美元。分析期間，轉染設備領域的複合年成長率預計為 5.3%。

美國市場預估為3.241億美元，中國預期複合年成長率為5.7%

預計2023年美國轉染試劑和設備市場規模將達3.241億美元。中國作為全球第二大經濟體，預計2030年市場規模將達2.827億美元，2023-2030年複合年成長率為5.7%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 5.3% 和 5.2%。在歐洲，德國的複合年成長率預計為 4.7%。

全球轉染試劑和設備市場 - 主要趨勢和促進因素總結

什麼是轉染試劑和設備以及為什麼需要它們？

轉染試劑和設備是分子生物學和遺傳學研究中用於將核酸（DNA 或 RNA）引入細胞的重要工具。這些工具對於各種應用至關重要，包括基因表現研究、蛋白質生產和基因改造生物的開發。轉染試劑，例如脂質、聚合物和電穿孔溶液，透過促進核酸的攝取和表現來促進核酸進入細胞。電穿孔器和顯微注射器等轉染設備提供了實現高效可靠轉染所需的技術。這些工具對於提高我們對基因功能、疾病機制和新療法開發的理解至關重要。

轉染試劑和設備如何促進基因研究？

轉染試劑和設備透過提供可靠且有效的方法將遺傳物質引入細胞來促進遺傳研究。這些工具使研究人員能夠研究基因功能和調控、建立疾病模型並開發基於基因的治療方法。先進的轉染試劑已被開發用於提高轉染效率、降低細胞毒性並能夠遞送大或複雜的核酸。例如，電穿孔裝置利用電脈衝在細胞膜上產生臨時孔，使核酸能夠有效率地進入細胞。透過最佳化轉染過程，這些試劑和儀器促進了準確且可重複的實驗，加速了科學發現和創新療法的開發。

為什麼轉染試劑和設備的需求不斷增加？

由於幾個重要因素，對轉染試劑和設備的需求增加。隨著基因功能的闡明和基因療法的發展，遺傳和基因組研究的增加推動了對先進轉染工具的需求。生物技術的進步，包括 CRISPR-Cas9 和其他基因編輯技術，需要有效的轉染方法才能成功。對個人化醫療和標靶治療的日益關注也推動了對可靠轉染系統的需求，以開發和測試新治療方法。此外，生物技術和製藥行業的成長以及研發資金的增加正在支持轉染試劑和設備市場的擴張。學術和工業研究對高效且高度可重複的轉染方法的需求也推動了轉染方法的廣泛使用。

推動轉染試劑和設備市場成長的因素有哪些？

轉染試劑和設備市場的成長受到多種因素的推動。人們對基因研究和基因治療開發的日益關注需要先進的轉染工具來促進這些研究。轉染試劑和裝置的技術進步，例如改進的遞送方法和降低的細胞毒性，提高了它們的效率和可靠性，並促進了它們的採用。生物技術和製藥領域的擴張以及研究經費的增加正在支持市場的成長。個人化醫療的興起和對標靶治療的需求也推動了對高效轉染系統的需求。此外，CRISPR-Cas9等基因編輯技術的廣泛應用需要可靠的轉染方法，進一步推動市場成長。對開發遺傳性疾病和癌症新治療方法的重視強調了轉染試劑和設備在推進醫學研究和治療開發中的重要性。

受訪企業範例（42家知名企業）

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Life Technologies Corporation
  • Lonza Group AG
  • MilliporeSigma
  • PolyPlus Battery Company（PPBC）
  • Promega Corporation
  • Qiagen NV
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP15289

Global Transfection Reagents and Equipment Market to Reach US$1.8 Billion by 2030

The global market for Transfection Reagents and Equipment estimated at US$1.2 Billion in the year 2023, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Transfection Reagents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Transfection Equipment segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$324.1 Million While China is Forecast to Grow at 5.7% CAGR

The Transfection Reagents and Equipment market in the U.S. is estimated at US$324.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$282.7 Million by the year 2030 trailing a CAGR of 5.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.3% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Transfection Reagents and Equipment Market - Key Trends & Drivers Summarized

What are Transfection Reagents and Equipment and Why are They Essential?

Transfection Reagents and Equipment are crucial tools used in molecular biology and genetic research to introduce nucleic acids (DNA or RNA) into cells. These tools are essential for various applications, including gene expression studies, protein production, and the development of genetically modified organisms. Transfection reagents, such as lipids, polymers, and electroporation solutions, facilitate the delivery of nucleic acids into cells by promoting their uptake and expression. Transfection equipment, including electroporators and microinjectors, provides the necessary technology to achieve efficient and reliable transfection. These tools are fundamental for advancing our understanding of gene function, disease mechanisms, and the development of novel therapeutics.

How Do Transfection Reagents and Equipment Enhance Genetic Research?

Transfection Reagents and Equipment enhance genetic research by providing reliable and efficient methods for introducing genetic material into cells. These tools enable researchers to study gene function and regulation, model diseases, and develop gene-based therapies. Advanced transfection reagents have been developed to improve transfection efficiency, reduce cytotoxicity, and enable the delivery of large or complex nucleic acids. Electroporation equipment, for instance, uses electrical pulses to create temporary pores in cell membranes, allowing nucleic acids to enter cells with high efficiency. By optimizing the transfection process, these reagents and equipment facilitate accurate and reproducible experiments, accelerating scientific discoveries and the development of innovative treatments.

Why is the Demand for Transfection Reagents and Equipment Increasing?

The demand for Transfection Reagents and Equipment is increasing due to several critical factors. The rise in genetic and genomic research, driven by the growing understanding of gene functions and the development of gene therapies, fuels the need for advanced transfection tools. Advances in biotechnology, including CRISPR-Cas9 and other gene-editing technologies, require efficient transfection methods for successful implementation. The increasing focus on personalized medicine and targeted therapies also drives the demand for reliable transfection systems to develop and test new treatments. Additionally, the growth of the biotechnology and pharmaceutical industries, along with increased funding for research and development, supports the expanding market for transfection reagents and equipment. The need for efficient and reproducible transfection methods in academic and industrial research further contributes to their widespread adoption.

What Factors are Driving the Growth of the Transfection Reagents and Equipment Market?

The growth in the Transfection Reagents and Equipment market is driven by several factors. The increasing focus on genetic research and the development of gene therapies necessitate advanced transfection tools to facilitate these studies. Technological advancements in transfection reagents and equipment, such as improved delivery methods and reduced cytotoxicity, enhance their efficiency and reliability, driving their adoption. The expansion of the biotechnology and pharmaceutical sectors, coupled with increased research funding, supports market growth. The rise of personalized medicine and the need for targeted therapies also propel the demand for efficient transfection systems. Additionally, the growing application of gene editing technologies like CRISPR-Cas9 requires reliable transfection methods, further boosting market growth. The emphasis on developing novel treatments for genetic disorders and cancers underscores the importance of transfection reagents and equipment in advancing medical research and therapeutic development.

Select Competitors (Total 42 Featured) -

  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Life Technologies Corporation
  • Lonza Group AG
  • MilliporeSigma
  • PolyPlus Battery Company (PPBC)
  • Promega Corporation
  • Qiagen NV
  • SignaGen Laboratories
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transfection Reagents and Equipment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Gene Therapy and Genetic Research
    • Technological Innovations in Transfection Methods
    • Expansion of Biotechnology and Pharmaceutical Industries
    • Increasing Investment in Cancer Research and Immunotherapy
    • Regulatory Approvals and Advancements in Clinical Applications
    • Growing Adoption of High-Throughput Screening
    • Market Demand for Efficient and Reliable Reagents
    • Impact of Personalized Medicine on Transfection Techniques
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Gene Expression Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Gene Expression Studies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Gene Expression Studies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Protein Production by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Protein Production by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Transgenic Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Transgenic Models by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Transgenic Models by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Therapeutic Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Therapeutic Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Transfection Reagents and Equipment Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Transfection Reagents and Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Transfection Reagents and Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Electroporation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Electroporation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Electroporation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Liposomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Particle Bombardment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Particle Bombardment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Particle Bombardment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Microinjection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Microinjection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Adenoviral Vectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Adenoviral Vectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Adenoviral Vectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Calcium Phosphate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Calcium Phosphate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Calcium Phosphate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: World 16-Year Perspective for Other Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • JAPAN
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • CHINA
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: China 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: China 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • EUROPE
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Transfection Reagents and Equipment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Transfection Reagents and Equipment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • FRANCE
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: France 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: France 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • GERMANY
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: UK 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transfection Reagents and Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Transfection Reagents and Equipment by Application - Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Application - Percentage Breakdown of Value Sales for Gene Expression Studies, Protein Production, Transgenic Models, Therapeutic Delivery and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Segment - Reagents and Equipment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Transfection Reagents and Equipment by Segment - Reagents and Equipment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Segment - Percentage Breakdown of Value Sales for Reagents and Equipment for the Years 2014, 2024 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for Transfection Reagents and Equipment by Method - Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of World 16-Year Perspective for Transfection Reagents and Equipment by Method - Percentage Breakdown of Value Sales for Electroporation, Liposomes, Particle Bombardment, Microinjection, Adenoviral Vectors, Calcium Phosphate and Other Methods for the Years 2014, 2024 & 2030

IV. COMPETITION